Ultragenyx Pharmaceutical Inc (RARE)

05:08 AM

Does Ultragenyx Pharmaceutical Inc. fit your quant trading modelJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com

05:08 AM

12:49 PM

Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reports2025 Big Picture & Community Trade Idea Sharing Platform - newser.com

12:49 PM

Oct 12, 2025

Sentiment analysis tools applied to Ultragenyx Pharmaceutical Inc.Market Sentiment Review & Safe Capital Growth Stock Tips - newser.com

Oct 12, 2025

Oct 11, 2025

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2025

Oct 11, 2025

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 11, 2025

Oct 10, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com

Oct 10, 2025

Oct 10, 2025

Ultragenyx Pharmaceutical Inc. stock prediction for this weekWeekly Trade Review & Reliable Trade Execution Plans - newser.com

Oct 10, 2025

Oct 10, 2025

What sentiment indicators say about Ultragenyx Pharmaceutical Inc. stockCPI Data & Capital Protection Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE) - MarketBeat

Oct 09, 2025

Oct 09, 2025

What moving averages say about Ultragenyx Pharmaceutical Inc.2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com

Oct 09, 2025

Oct 09, 2025

Does Ultragenyx Pharmaceutical Inc. show high probability of reboundWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com

Oct 09, 2025

Oct 09, 2025

Predicting Ultragenyx Pharmaceutical Inc. trend using moving averagesJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com

Oct 09, 2025

Oct 09, 2025

What drives Ultragenyx Pharmaceutical Inc stock priceTechnical Analysis Insights & Hidden Gems with Outstanding Profit Margins - earlytimes.in

Oct 09, 2025

Oct 08, 2025

Wealth Enhancement Advisory Services LLC Takes $353,000 Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Oct 08, 2025

Oct 08, 2025

Bank of America Securities Remains Bullish on Ultragenyx Pharmaceutical (RARE) - Yahoo Finance

Oct 08, 2025

Oct 06, 2025

Pattern recognition hints at Ultragenyx Pharmaceutical Inc. upsideWeekly Volume Report & High Conviction Buy Zone Picks - newser.com

Oct 06, 2025

Oct 06, 2025

Why Ultragenyx Pharmaceutical Inc. (UP0) stock signals breakout potentialJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025

Oct 06, 2025

How to read the order book for Ultragenyx Pharmaceutical Inc.Share Buyback & Free Daily Entry Point Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Ultragenyx Pharmaceutical Inc. stock trend outlook and recovery path2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Will Ultragenyx Pharmaceutical Inc. (UP0) stock outperform energy sector in 2025Watch List & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛

Oct 04, 2025

Oct 03, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

62,232 Options & 34,564 RSUs: Ultragenyx Grants Inducement Award to New Hire, Grant Date Sep 30, 2025 - Stock Titan

Oct 03, 2025

Oct 03, 2025

Ultragenyx Pharmaceutical (RARE): Valuation Perspectives Following Regulatory Milestones and Pipeline Progress - Yahoo Finance

Oct 03, 2025

Oct 03, 2025

Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Strategic Leadership Transition with Eric Olson - Sahm

Oct 03, 2025

Oct 03, 2025

Using RSI to spot recovery in Ultragenyx Pharmaceutical Inc.Weekly Investment Recap & Smart Money Movement Tracker - newser.com

Oct 03, 2025

Oct 03, 2025

Tools to monitor Ultragenyx Pharmaceutical Inc. recovery probabilityAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

How to monitor Ultragenyx Pharmaceutical Inc. with trend dashboards2025 Short Interest & High Return Trade Guides - newser.com

Oct 03, 2025

Oct 02, 2025

How Might Ultragenyx (RARE) Leverage Dealmaking Expertise to Shape Its Long-Term Growth Strategy? - Yahoo Finance

Oct 02, 2025

Oct 02, 2025

Ultragenyx (RARE) Poised for Positive Developments, Says JPMorga - GuruFocus

Oct 02, 2025

Oct 02, 2025

Assenagon Boosts Ultragenyx Pharmaceutical Inc. (RARE) Stake by 439% Amid Breakthrough Pipeline - Insider Monkey

Oct 02, 2025

Oct 01, 2025

Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical - openPR.com

Oct 01, 2025

Oct 01, 2025

Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical Progress by 8+ Global Leaders – DelveInsight | Featuring Ultragenyx Pharmaceutical Inc, JCR Pharmaceuticals Co., Ltd., GC Biopharma Corp, D - The Globe and Mail

Oct 01, 2025

Oct 01, 2025

Ultragenyx Pharmaceutical Hits Day High with Strong 8.12% Intraday Surge - Markets Mojo

Oct 01, 2025

Oct 01, 2025

Ultragenyx Pharmaceutical Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 01, 2025

Oct 01, 2025

United States Osteogenesis Imperfecta Treatment Market - openPR.com

Oct 01, 2025

Oct 01, 2025

Ultragenyx appoints Eric Olson as chief business officer By Investing.com - Investing.com Nigeria

Oct 01, 2025

Sep 30, 2025

Revolution Medicines hires Mirati, ALX vet Sandler - biocentury.com

Sep 30, 2025

Sep 30, 2025

7 Most Promising Biotech Stocks to Buy According to Hedge Funds - Insider Monkey

Sep 30, 2025

Sep 30, 2025

Ultragenyx appoints Eric Olson as chief business officer and executive vice president - MarketScreener

Sep 30, 2025

Sep 30, 2025

Ultragenyx appoints Eric Olson as chief business officer - Investing.com India

Sep 30, 2025

Sep 30, 2025

Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President - GlobeNewswire

Sep 30, 2025